Requests that the FDA revert to its longstanding policy of allowing manufacturers to market dietary supplements containing NAC and rescind the legally invalid position included in warning letters11 that NAC is precluded by section 201(ff)(3)(B)(i) of the FDCA from being a legal dietary ingredient in dietary supplements; CLOSED

1 organizations filed 1 public comment on Requests that the FDA revert to its longstanding policy of allowing manufacturers to market dietary supplements containing NAC and rescind the legally invalid position included in warning letters11 that NAC is precluded by section 201(ff)(3)(B)(i) of the FDCA from being a legal dietary ingredient in dietary supplements; CLOSED, at the Food and Drug Administration.

Abstract

CLOSED

Commenters (1)

• Consumer Healthcare Products Associationtrade assoc.

  1 filing · confidence 97%